Skip to content

Efficacy of 0.01% atropine eye drops combined with functional defocus spectacle lenses in controlling low myopia progression in children

Efficacy of 0.01% atropine eye drops combined with functional defocus spectacle lenses in controlling low myopia progression in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120171
Enrollment
Unknown
Registered
2026-03-10
Start date
2025-02-18
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

0.01% atropine eye drops combined with functional defocus glasses :Use 0.01% atropine eye drops and defocus glasses at the same time as two prevention and control measures
0.01% atropine eye drops alone:0.01% atropine eye drops, once a night before bed
functional defocus glasses alone:Wear glasses for more than 12 hours a day

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Age 7-12 years old 2.Equivalent spherical power after cycloplegia optometry-0.50 D--3.00 D Astigmatism =-1.50 D 3.BCVA = 1.0 4.Intraocular pressure 10-21mmHg

Exclusion criteria

Exclusion criteria: 1.Poor near vision or poor adjustment ability 2.Previous use of orthokeratology lenses, contact lenses and other prevention and control methods 3.Strabismus, amblyopia and other eye diseases or history of eye surgery 4.Allergy to the drugs in this study

Design outcomes

Primary

MeasureTime frame
Axial length ;

Secondary

MeasureTime frame
spherical equivalent refraction; Subfoveal Choroidal Thickness ;

Countries

China

Contacts

Public ContactZhao Qi

The Second Affiliated Hospital of Dalian Medical University

zhaoqidmu@126.com+86 133 0411 2073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026